ROCHESTER, NY—Formed by the sale of Kodak’s Flexographic Packaging Division to Montagu, Miraclon is a new independent company where Kodak FLEXCEL Solutions are brought to life for the package printing segment. A private equity firm, Miraclon is a global company with more than 300 employees, an innovative R&D team, manufacturing operations in the US and Japan, and a passion for flexo.
Miraclon will concentrate fully on the development, production and sale of its industry-leading Kodak FLEXCEL Solutions, including the flagship Kodak FLEXCEL NX System. Under Montagu’s ownership, the company intends to further strengthen its role as a technology enabler of change as flexographic printing is transformed into a premium printing process for packaging.
Chris Payne, who has been leading Kodak’s Flexographic Packaging Division since January 2015, is the new company’s CEO and will continue to lead the team responsible for the development and dynamic growth of Kodak’s flexo business. “Customers will experience the same products, same people and same trusted Kodak product brand that they have come to depend upon to support their own business growth. Together with our customers, we’ve played a decisive role in shaping flexo’s evolution over the last 10 years, and we’re now looking forward, as Miraclon, to being the driving force behind the next evolution of Kodak FLEXCEL Solutions, and setting new benchmarks for years to come,” said Payne.
Miraclon has offices around the globe, from Brussels, Belgium and Rochester, NY to Guadalajara, Mexico and Singapore, with R&D centers in Minnesota, Vancouver and Israel as well as two key manufacturing locations and a global supply chain operation. “My No. 1 priority is always the customer,” Payne added. “I know it sounds like a cliché, but it’s at the heart of everything we do. We will continue to push back the limits of what is technically possible in flexo printing with innovative Kodak FLEXCEL Solutions, and help our customers grow and be successful.”
You must be logged in to post a comment.